These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7690117)

  • 1. Are 5-HT1A autoreceptors involved in the inhibitory effect of ipsapirone on cold-elicited thyrotropin secretion?
    Broqua P; Laude D; Bluet-Pajot MT; Schmidt B; Baudrie V; Chaouloff F
    Neuroendocrinology; 1993 Apr; 57(4):640-7. PubMed ID: 7690117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone, ipsapirone and 1-(2-pyrimidinyl)-piperazine decrease cold-induced thyrotropin secretion in rats.
    Broqua P; Baudrie V; Bluet-Pajot MT; Chaouloff F
    Eur J Pharmacol; 1991 Nov; 204(2):141-7. PubMed ID: 1687218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses.
    Zamfir O; Broqua P; Baudrie V; Chaouloff F
    Eur J Pharmacol; 1992 Aug; 219(2):261-9. PubMed ID: 1385172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex actions of serotonergic agonists on cold-stimulated TSH secretion in male rats.
    Toivonen M; Männistö PT
    Eur J Pharmacol; 1990 May; 180(1):91-102. PubMed ID: 2142094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
    Schreiber R; Opitz K; Glaser T; De Vry J
    Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE; Farrar GE; Dunn AJ; Saphier D
    Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of serotonin (5-HT1A and 5-HT2) agonists and antagonists on renin and corticosterone secretion.
    Lorens SA; Van de Kar LD
    Neuroendocrinology; 1987 Apr; 45(4):305-10. PubMed ID: 2952898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
    Gilbert F; Brazell C; Tricklebank MD; Stahl SM
    Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of cerebellar Purkinje cells to serotonin and the 5-HT1A agonists 8-OH-DPAT and ipsapirone in vitro.
    Darrow EJ; Strahlendorf HK; Strahlendorf JC
    Eur J Pharmacol; 1990 Jan; 175(2):145-53. PubMed ID: 1968842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
    Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T
    Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant/anxiolytic ipsapirone inhibits cold-induced hypothalamic TRH release.
    Broqua P; Benyassi A; Grouselle D; Arancibia S
    Neuroreport; 1993 Sep; 4(10):1200-2. PubMed ID: 8106004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist.
    Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):121-6. PubMed ID: 1448177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blockade in rats enhances the ambulation induced by 5-HT1A receptor agonists.
    Kalkman HO
    Eur J Pharmacol; 1989 Dec; 173(2-3):121-5. PubMed ID: 2576226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.